Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,551 | 45 | 99.0% |
| Education | $16.14 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $266.56 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $225.14 | 2 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $192.03 | 10 | $0 (2024) |
| Ardelyx, Inc. | $174.48 | 8 | $0 (2024) |
| DePuy Synthes Sales Inc. | $125.03 | 1 | $0 (2017) |
| Ethicon US, LLC | $116.81 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $101.87 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $101.71 | 1 | $0 (2018) |
| Allergan Inc. | $80.60 | 1 | $0 (2018) |
| PFIZER INC. | $51.69 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $646.62 | 32 | Janssen Biotech, Inc. ($241.88) |
| 2023 | $81.40 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($39.87) |
| 2022 | $16.14 | 1 | E.R. Squibb & Sons, L.L.C. ($16.14) |
| 2021 | $19.86 | 1 | Boston Scientific Corporation ($19.86) |
| 2018 | $399.26 | 4 | Ethicon US, LLC ($116.81) |
| 2017 | $403.59 | 4 | DePuy Synthes Sales Inc. ($125.03) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Immunology | ||||||
| 09/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Immunology | ||||||
| 09/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Immunology | ||||||
| 08/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Immunology | ||||||
| 06/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Immunology | ||||||
| 06/10/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Immunology | ||||||
| 06/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Immunology | ||||||
| 04/15/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Immunology | ||||||
| 04/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 798 | 833 | $460,595 | $85,176 |
| 2022 | 11 | 784 | 878 | $431,380 | $86,335 |
| 2021 | 13 | 860 | 948 | $494,225 | $94,041 |
| 2020 | 18 | 786 | 869 | $335,884 | $69,176 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 156 | 159 | $150,905 | $18,922 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 214 | $46,270 | $14,815 | 32.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 61 | 61 | $72,980 | $13,330 | 18.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 127 | 129 | $85,240 | $9,883 | 11.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 115 | 115 | $30,685 | $8,461 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $21,795 | $6,513 | 29.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 19 | 19 | $11,925 | $3,565 | 29.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 21 | 22 | $19,520 | $3,160 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 28 | $8,580 | $3,042 | 35.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 16 | 16 | $10,050 | $2,800 | 27.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 15 | 15 | $2,645 | $684.61 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 215 | 300 | $63,755 | $21,193 | 33.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 113 | 115 | $112,365 | $14,568 | 13.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 51 | 52 | $62,980 | $10,895 | 17.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 110 | 111 | $76,155 | $9,150 | 12.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 96 | 96 | $27,420 | $7,659 | 27.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $21,305 | $6,263 | 29.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 23 | 23 | $16,630 | $4,454 | 26.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 17 | 18 | $12,685 | $3,269 | 25.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 63 | 63 | $12,425 | $3,113 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 30 | $9,235 | $2,975 | 32.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 21 | $16,425 | $2,796 | 17.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 179 | 234 | $49,140 | $17,678 | 36.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 71 | 72 | $89,280 | $15,917 | 17.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 134 | 139 | $102,860 | $11,194 | 10.9% |
About Dr. Frank Sammarco, M.D
Dr. Frank Sammarco, M.D is a Gastroenterology healthcare provider based in Norwalk, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407953920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Sammarco, M.D has received a total of $1,567 in payments from pharmaceutical and medical device companies, with $646.62 received in 2024. These payments were reported across 46 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,551).
As a Medicare-enrolled provider, Sammarco has provided services to 3,228 Medicare beneficiaries, totaling 3,528 services with total Medicare billing of $334,728. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Norwalk, CT
- Active Since 09/19/2006
- Last Updated 12/16/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1407953920
Products in Payments
- ENTRESTO (Drug) $225.14
- ENTYVIO (Biological) $192.03
- IBSRELA (Drug) $174.48
- TREMFYA (Drug) $153.73
- VIPER (Device) $125.03
- LINX Reflux Management System (Device) $116.81
- JANUVIA (Drug) $101.87
- SHINGRIX (Biological) $101.71
- STELARA (Biological) $88.15
- LINZESS (Drug) $80.60
- ELIQUIS (Drug) $51.69
- HYLENEX RECOMBINANT (Biological) $31.20
- RINVOQ (Biological) $27.60
- REMICADE (Biological) $24.68
- GENERAL GI DILATATION (Device) $19.86
- Omidria (Drug) $19.30
- ZEPOSIA (Drug) $16.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Norwalk
Sulieman Abdal Raheem, Md, MD
Gastroenterology — Payments: $2,886
Rakhee Mangla, M.d, M.D
Gastroenterology — Payments: $2,289
Dr. Charles Adelmann, M.d, M.D
Gastroenterology — Payments: $1,709
Dr. Muhammad Sarmini, M.d, M.D
Gastroenterology — Payments: $1,338
Dr. Yonatan Hillman, M.d, M.D
Gastroenterology — Payments: $355.87
Alfred Kafity, Do, DO
Gastroenterology — Payments: $173.16